A Double-Blind, Randomized, Placebo-Controlled Trial of Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder

Trial Profile

A Double-Blind, Randomized, Placebo-Controlled Trial of Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Jun 2014

At a glance

  • Drugs Ramelteon (Primary)
  • Indications Bipolar I disorders; Insomnia
  • Focus Therapeutic Use
  • Acronyms ram-TIME
  • Most Recent Events

    • 02 Jul 2010 Trial phase changed from II to IV as reported by ClinicalTrials.gov.
    • 02 Jul 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
    • 02 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top